Overview

Phase III Open Study, Prospective, Multicenter, Randomized, Comparative to the Positive Control for Evaluating the Efficacy and Safety of Auris-Sedina in the Symptomatic Control of Otalgy in Patients With or Without Acute External Otitis.

Status:
Unknown status
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and tolerability of Auris-Sedina in the symptomatic control of otalgy in patients with and without acute external otitis compared with use of Otosynalar®.
Phase:
Phase 3
Details
Lead Sponsor:
Laboratorios Osorio de Moraes Ltda.